Current Edition

early interventions to reduce
biopharmaceuticals

Early Interventions to Reduce the Impact of Immunogenicity on the Development of Biopharmaceuticals

The development of biological therapeutics has led to remarkable clinical benefits in many indications. But, despite this success, the induction of anti-drug antibodies (ADAs) due …

Continue Reading →